Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.2%

22 terminated/withdrawn out of 307 trials

Success Rate

88.2%

+1.6% vs industry average

Late-Stage Pipeline

14%

43 trials in Phase 3/4

Results Transparency

4%

7 of 165 completed trials have results

Key Signals

45 recruiting7 with results19 terminated

Enrollment Performance

Analytics

N/A
102(53.1%)
Phase 2
36(18.8%)
Phase 3
25(13.0%)
Phase 4
18(9.4%)
Phase 1
10(5.2%)
Early Phase 1
1(0.5%)
192Total
N/A(102)
Phase 2(36)
Phase 3(25)
Phase 4(18)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (307)

Showing 20 of 307 trials
NCT07856381Recruiting

Understanding Lifespan Trajectories of Social Cognition, Brain Microstructure and Iron Dysregulation in Schizophrenia

Role: collaborator

NCT07171281Not ApplicableRecruiting

Precise Eating Time to Improve Glycemic Control and Cardiometabolic Health in Prediabetes and Diabetes

Role: collaborator

NCT07837193Not ApplicableNot Yet Recruiting

Healthy Adaptation to Pregnancy, Postpartum and Parenthood

Role: collaborator

NCT02959242Recruiting

Dresden Glaucoma and Treatment Study (DGTS)

Role: lead

NCT04330820Phase 1Completed

Trial for Relapsed or Refractory AML Patients Combining Cytarabine and Mitoxantrone With Venetoclax (RELAX)

Role: lead

NCT02782910Not ApplicableCompleted

Smartphone-based Ambulatory Assessment of Early Warning Signs

Role: lead

NCT07025824Phase 2Recruiting

Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation

Role: lead

NCT04141709Not ApplicableActive Not Recruiting

Local Ablative Radiotherapy for OLIgoprogressive Castration Resistant Prostate Cancer

Role: lead

NCT02766686Not ApplicableCompleted

Preference-based Comparative Study on Definitive Radiotherapy of Prostate Cancer With Protons

Role: lead

NCT06937788Terminated

Replication of the Heads Up Atopic Dermatitis Trial With Registry Data

Role: lead

NCT05652361Not ApplicableRecruiting

Machine Learning-based Surgical Guidance System for Robot-assisted Rectal Surgery

Role: lead

NCT05836896Phase 1Recruiting

A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory B-cell Malignancies

Role: lead

NCT05904106Phase 2Recruiting

Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML

Role: lead

NCT07561385Not Yet Recruiting

Dresden MDS Registry With an Accompanying Biomaterial Collection

Role: lead

NCT06126601Recruiting

Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety

Role: lead

NCT05257746Recruiting

Perioperative and Postoperative Evaluation of Rectal and Urogenital Function in Patients Undergoing Rectal Resection

Role: lead

NCT05652348Recruiting

Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal Cancer

Role: lead

NCT05181982Recruiting

Evaluation of a Flexible and Integrative Psychiatric Care Model at the Pfalzklinikum (EVA_Pfalz)

Role: lead

NCT07561645Phase 2Not Yet Recruiting

A Trial for the Treatment of Advanced Large-Cell Neuroendocrine Cancer of the Lung

Role: lead

NCT06717958Phase 2Recruiting

Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Neoplasia With IDH1 (Isocitrate Dehydrogenase 1) Mutation

Role: lead